The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Insulin Lispro Market Outlook 2024

Global Insulin Lispro Market Outlook 2024

Publishing Date : Jan, 2022

License Type :
 

Report Code : 1663677

No of Pages : 95

Synopsis
Insulin lispro is synthetic insulin with a very rapid onset and short duration of action. Diabetic patients typically use it immediately before meals to prevent postprandial hyperglycemia. Its absorption is more rapid than regular insulin. It is made by reversing the amino acids lysine and proline in the beta chain of the insulin polypeptide.
In India, Insulin Lispro key players include Eli Lilly and Company, Gan & Lee Pharmaceuticals, etc. India top two manufacturers hold a share about 100%.
In terms of product, Mixed insulin aspart is the largest segment of Cobalt, with a share about 55%. And in terms of application, the largest application is Type 2 Diabetes, followed by Type 1 Diabetes.

The global Insulin Lispro market was valued at US$ million in 2020 and is expected to reach US$ million by the end of 2027, growing at a CAGR of % during 2021-2027.
This report focuses on Insulin Lispro volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Insulin Lispro market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.

Global Insulin Lispro Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type
Insulin aspart
Mixed insulin aspart

Segment by Application
Type 1 Diabetes
Type 2 Diabetes

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

By Company
Eli Lilly and Company
Gan & Lee Pharmaceuticals
Index
1 Insulin Lispro Market Overview
1.1 Product Overview and Scope of Insulin Lispro
1.2 Insulin Lispro Segment by Type
1.2.1 Global Insulin Lispro Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Insulin aspart
1.2.3 Mixed insulin aspart
1.3 Insulin Lispro Segment by Application
1.3.1 Global Insulin Lispro Sales Comparison by Application: (2021-2027)
1.3.2 Type 1 Diabetes
1.3.3 Type 2 Diabetes
1.4 Global Insulin Lispro Market Size Estimates and Forecasts
1.4.1 Global Insulin Lispro Revenue 2016-2027
1.4.2 Global Insulin Lispro Sales 2016-2027
1.4.3 Insulin Lispro Market Size by Region: 2016 Versus 2021 Versus 2027

2 Insulin Lispro Market Competition by Manufacturers
2.1 Global Insulin Lispro Sales Market Share by Manufacturers (2016-2021)
2.2 Global Insulin Lispro Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Insulin Lispro Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Insulin Lispro Manufacturing Sites, Area Served, Product Type
2.5 Insulin Lispro Market Competitive Situation and Trends
2.5.1 Insulin Lispro Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Insulin Lispro Players Market Share by Revenue
2.5.3 Global Insulin Lispro Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Insulin Lispro Retrospective Market Scenario by Region
3.1 Global Insulin Lispro Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Insulin Lispro Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Insulin Lispro Market Facts & Figures by Country
3.3.1 North America Insulin Lispro Sales by Country
3.3.2 North America Insulin Lispro Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Insulin Lispro Market Facts & Figures by Country
3.4.1 Europe Insulin Lispro Sales by Country
3.4.2 Europe Insulin Lispro Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Insulin Lispro Market Facts & Figures by Region
3.5.1 Asia Pacific Insulin Lispro Sales by Region
3.5.2 Asia Pacific Insulin Lispro Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Insulin Lispro Market Facts & Figures by Country
3.6.1 Latin America Insulin Lispro Sales by Country
3.6.2 Latin America Insulin Lispro Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Insulin Lispro Market Facts & Figures by Country
3.7.1 Middle East and Africa Insulin Lispro Sales by Country
3.7.2 Middle East and Africa Insulin Lispro Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Insulin Lispro Historic Market Analysis by Type
4.1 Global Insulin Lispro Sales Market Share by Type (2016-2021)
4.2 Global Insulin Lispro Revenue Market Share by Type (2016-2021)
4.3 Global Insulin Lispro Price by Type (2016-2021)

5 Global Insulin Lispro Historic Market Analysis by Application
5.1 Global Insulin Lispro Sales Market Share by Application (2016-2021)
5.2 Global Insulin Lispro Revenue Market Share by Application (2016-2021)
5.3 Global Insulin Lispro Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Eli Lilly and Company
6.1.1 Eli Lilly and Company Corporation Information
6.1.2 Eli Lilly and Company Description and Business Overview
6.1.3 Eli Lilly and Company Insulin Lispro Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Eli Lilly and Company Insulin Lispro Product Portfolio
6.1.5 Eli Lilly and Company Recent Developments/Updates
6.2 Gan & Lee Pharmaceuticals
6.2.1 Gan & Lee Pharmaceuticals Corporation Information
6.2.2 Gan & Lee Pharmaceuticals Description and Business Overview
6.2.3 Gan & Lee Pharmaceuticals Insulin Lispro Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Gan & Lee Pharmaceuticals Insulin Lispro Product Portfolio
6.2.5 Gan & Lee Pharmaceuticals Recent Developments/Updates

7 Insulin Lispro Manufacturing Cost Analysis
7.1 Insulin Lispro Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Insulin Lispro
7.4 Insulin Lispro Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Insulin Lispro Distributors List
8.3 Insulin Lispro Customers

9 Insulin Lispro Market Dynamics
9.1 Insulin Lispro Industry Trends
9.2 Insulin Lispro Growth Drivers
9.3 Insulin Lispro Market Challenges
9.4 Insulin Lispro Market Restraints

10 Global Market Forecast
10.1 Insulin Lispro Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Insulin Lispro by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Insulin Lispro by Type (2022-2027)
10.2 Insulin Lispro Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Insulin Lispro by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Insulin Lispro by Application (2022-2027)
10.3 Insulin Lispro Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Insulin Lispro by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Insulin Lispro by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
List of Tables
Table 1. Global Insulin Lispro Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Insulin Lispro Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Insulin Lispro Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Insulin Lispro Covered in This Study
Table 5. Global Insulin Lispro Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Insulin Lispro Sales Market Share by Manufacturers (2016-2021)
Table 7. Global Insulin Lispro Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Insulin Lispro Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Insulin Lispro Average Price (USD/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Insulin Lispro Manufacturing Sites and Area Served
Table 11. Manufacturers Insulin Lispro Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Insulin Lispro by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Insulin Lispro as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Insulin Lispro Sales by Region (2016-2021) & (K Units)
Table 16. Global Insulin Lispro Sales Market Share by Region (2016-2021)
Table 17. Global Insulin Lispro Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Insulin Lispro Sales by Country (2016-2021) & (K Units)
Table 19. North America Insulin Lispro Sales Market Share by Country (2016-2021)
Table 20. North America Insulin Lispro Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Insulin Lispro Revenue Market Share by Country (2016-2021)
Table 22. Europe Insulin Lispro Sales by Country (2016-2021) & (K Units)
Table 23. Europe Insulin Lispro Sales Market Share by Country (2016-2021)
Table 24. Europe Insulin Lispro Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Insulin Lispro Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Insulin Lispro Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Insulin Lispro Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Insulin Lispro Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Insulin Lispro Revenue Market Share by Region (2016-2021)
Table 30. Latin America Insulin Lispro Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Insulin Lispro Sales Market Share by Country (2016-2021)
Table 32. Latin America Insulin Lispro Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Insulin Lispro Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Insulin Lispro Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Insulin Lispro Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Insulin Lispro Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Insulin Lispro Revenue Market Share by Country (2016-2021)
Table 38. Global Insulin Lispro Sales (K Units) by Type (2016-2021)
Table 39. Global Insulin Lispro Sales Market Share by Type (2016-2021)
Table 40. Global Insulin Lispro Revenue (Million US$) by Type (2016-2021)
Table 41. Global Insulin Lispro Revenue Share by Type (2016-2021)
Table 42. Global Insulin Lispro Price (USD/Unit) by Type (2016-2021)
Table 43. Global Insulin Lispro Sales (K Units) by Application (2016-2021)
Table 44. Global Insulin Lispro Sales Market Share by Application (2016-2021)
Table 45. Global Insulin Lispro Revenue (Million US$) by Application (2016-2021)
Table 46. Global Insulin Lispro Revenue Share by Application (2016-2021)
Table 47. Global Insulin Lispro Price (USD/Unit) by Application (2016-2021)
Table 48. Eli Lilly and Company Corporation Information
Table 49. Eli Lilly and Company Description and Business Overview
Table 50. Eli Lilly and Company Insulin Lispro Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 51. Eli Lilly and Company Insulin Lispro Product
Table 52. Eli Lilly and Company Recent Developments/Updates
Table 53. Gan & Lee Pharmaceuticals Corporation Information
Table 54. Gan & Lee Pharmaceuticals Description and Business Overview
Table 55. Gan & Lee Pharmaceuticals Insulin Lispro Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 56. Gan & Lee Pharmaceuticals Insulin Lispro Product
Table 57. Gan & Lee Pharmaceuticals Recent Developments/Updates
Table 58. Production Base and Market Concentration Rate of Raw Material
Table 59. Key Suppliers of Raw Materials
Table 60. Insulin Lispro Distributors List
Table 61. Insulin Lispro Customers List
Table 62. Insulin Lispro Market Trends
Table 63. Insulin Lispro Growth Drivers
Table 64. Insulin Lispro Market Challenges
Table 65. Insulin Lispro Market Restraints
Table 66. Global Insulin Lispro Sales Forecast by Type (2022-2027) & (K Units)
Table 67. Global Insulin Lispro Sales Market Share Forecast by Type (2022-2027)
Table 68. Global Insulin Lispro Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 69. Global Insulin Lispro Revenue Market Share Forecast by Type (2022-2027)
Table 70. Global Insulin Lispro Sales Forecast by Application (2022-2027) & (K Units)
Table 71. Global Insulin Lispro Sales Market Share Forecast by Application (2022-2027)
Table 72. Global Insulin Lispro Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 73. Global Insulin Lispro Revenue Market Share Forecast by Application (2022-2027)
Table 74. Global Insulin Lispro Sales Forecast by Region (2022-2027) & (K Units)
Table 75. Global Insulin Lispro Sales Market Share Forecast by Region (2022-2027)
Table 76. Global Insulin Lispro Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 77. Global Insulin Lispro Revenue Market Share Forecast by Region (2022-2027)
Table 78. Research Programs/Design for This Report
Table 79. Key Data Information from Secondary Sources
Table 80. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Insulin Lispro
Figure 2. Global Insulin Lispro Market Share by Type in 2020 & 2027
Figure 3. Insulin aspart Product Picture
Figure 4. Mixed insulin aspart Product Picture
Figure 5. Global Insulin Lispro Market Share by Application in 2020 & 2027
Figure 6. Type 1 Diabetes
Figure 7. Type 2 Diabetes
Figure 8. Global Insulin Lispro Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 9. Global Insulin Lispro Market Size 2016-2027 (US$ Million)
Figure 10. Global Insulin Lispro Sales 2016-2027 (K Units)
Figure 11. Global Insulin Lispro Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 12. Insulin Lispro Sales Share by Manufacturers in 2020
Figure 13. Global Insulin Lispro Revenue Share by Manufacturers in 2020
Figure 14. The Global 5 and 10 Largest Insulin Lispro Players: Market Share by Revenue in 2020
Figure 15. Insulin Lispro Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 16. Global Insulin Lispro Sales Market Share by Region (2016-2021)
Figure 17. Global Insulin Lispro Sales Market Share by Region in 2020
Figure 18. Global Insulin Lispro Revenue Market Share by Region (2016-2021)
Figure 19. Global Insulin Lispro Revenue Market Share by Region in 2020
Figure 20. U.S. Insulin Lispro Revenue Growth Rate (2016-2021) (US$ Million)
Figure 21. Canada Insulin Lispro Revenue Growth Rate (2016-2021) (US$ Million)
Figure 22. Germany Insulin Lispro Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. France Insulin Lispro Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. U.K. Insulin Lispro Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. Italy Insulin Lispro Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Russia Insulin Lispro Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. China Insulin Lispro Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Japan Insulin Lispro Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. South Korea Insulin Lispro Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. India Insulin Lispro Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. Australia Insulin Lispro Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Taiwan Insulin Lispro Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Indonesia Insulin Lispro Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Thailand Insulin Lispro Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Malaysia Insulin Lispro Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Philippines Insulin Lispro Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Vietnam Insulin Lispro Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Mexico Insulin Lispro Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Brazil Insulin Lispro Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Argentina Insulin Lispro Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Turkey Insulin Lispro Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Saudi Arabia Insulin Lispro Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. UAE Insulin Lispro Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Sales Market Share of Insulin Lispro by Type (2016-2021)
Figure 45. Sales Market Share of Insulin Lispro by Application (2016-2021)
Figure 46. Sales Market Share of Insulin Lispro by Application in 2020
Figure 47. Revenue Share of Insulin Lispro by Application (2016-2021)
Figure 48. Revenue Share of Insulin Lispro by Application in 2020
Figure 49. Manufacturing Cost Structure of Insulin Lispro
Figure 50. Manufacturing Process Analysis of Insulin Lispro
Figure 51. Insulin Lispro Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’